Sartorius BIOSTAT STR Generation 3 bioreactor with BIOBRAIN automation platform
11 March, 2020Engineered to address the rigorous requirements and complexity of biologics manufacture, Sartorius's BIOSTAT STR Generation 3 bioreactor is a robust industrial platform consisting of hardware, software and consumables for single-use process development and commercial biomanufacturing.
FDA approves new drug for Duchenne muscular dystrophy
05 March, 2020A clinical trial of the drug, known as VYONDYS 53 (golodirsen), established that it was well tolerated and acted to restore dystrophin protein.
Queensland and India form bioscience alliance
04 March, 2020Life Sciences Queensland (LSQ) has formed a partnership with India's Association of Biotechnology Led Enterprises (ABLE).
DuPont DELRIN SC698 resin for medical devices
11 February, 2020The DELRIN SC698 resin with integrated lubrication can help improve patient comfort and ease of use by ensuring smooth actuation of high-load drug delivery devices like inhalers, injectors and pumps.
New drug combination destroys deadly bacterial infection
30 January, 2020The treatment has been found to completely kill a bacterial infection that can be deadly to patients with cystic fibrosis and other chronic lung conditions such as bronchiectasis.
Promising drug compounds target liver cancer
23 January, 2020Singaporean scientists have discovered four potential drug compounds that target hepatocellular carcinoma (HCC), the most common type of liver cancer.
Blood pressure drug could help treat alcoholism
22 January, 2020A drug used to treat high blood pressure may alleviate anxiety induced by long-term heavy alcohol use, and also halt the damage such drinking can cause to the brain's ability to grow new cells.
Human livers kept alive for one week outside the body
14 January, 2020With novel perfusion technology, livers — even injured livers — can now be kept alive outside of the body for an entire week.
Anticancer candidate trialled in solid tumours
10 January, 2020Life sciences company QBiotics has announced positive results from its first-in-human Phase I clinical trial of its anticancer pharmaceutical, tigilanol tiglate (EBC-46).
Alzheimer's drug candidates found to reverse broader ageing
17 December, 2019The drug candidates may be useful for treating a broad array of conditions, and suggest a new pathway that links normal ageing to Alzheimer's disease.
Ovarian cancer shrinks by more than 50% in preclinical trial
16 December, 2019The Hudson Institute of Medical Research has completed a preclinical study investigating Invion's Photosoft compound on mice with ovarian cancer — with promising results.
Medtech community shares the secrets of commercialisation
09 December, 2019Saving and improving lives by making it easier to develop medical devices with electronics and software is the mission of the newly launched NSW Active MedTech Community.
Major Project Status granted for medical cannabis facilities
06 December, 2019The Australian Government is looking to maximise the economic potential of the medicinal cannabis industry.
Contraceptive patch delivers hormone via microneedles
20 November, 2019US scientists have developed a contraceptive patch with a novel effervescent backing that separates from an array of microneedles after one minute.
Ultrasonic waves used to target drugs to tumours
19 November, 2019USC biomedical engineers have proposed a new ultrasonic method to enable acoustic control and real-time tracking of cancer drugs within the body.
